You are here: Industry Insights > biomarker

News List

The Landscape of Biomarkers: From Traditional Measures to Multi-Omics Powerhouses Shruti Talshi
February 18, 2024
A biomarker is an indicator that can be quantified to show whether a biological process is pathogenic, normal, or responding to an intervention or exposure.
Research Progress in Signaling Pathway and Related Drugs of Target GDF15 Xiaonisha/PharmaSources
April 19, 2023
GDF15 being a kind of endocrine hormone and a member of transforming growth factor β superfamily, acts as an autocrine regulatory molecule in macrophages, which was identified and found from the clone of activated macrophage cell line.
Biomarker may uncover uncontrolled asthma in adults, children: Research expresspharma
August 23, 2019
Cytokine interleukin(IL)-26 could be used as biological marker for uncontrolled asthma in adults, children – could be future goal for new drugs against asthma
Evolving World of Pharma: Addressing real-world challenges in personalized medicine Sarah Harding
June 25, 2019
Earlier this year I wrote about a new model for healthcare – one of ‘personalized medicine’ – in which all patients receive exactly the right diagnoses and treatments, personalized to them as individuals.
Definiens & Targos Innovation: AI-powered multiplex IHC biomarker analytic solutions for precision medicine En-CPhI.cn
June 24, 2019
Definiens and Targos announced a collaboration for the integration of AI-powered data and multi-omics analytics of the tumor microenvironment with multiplexed immunohistochemistry (IHC) assay development in precision medicine global clinical trials.
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer drugs
June 11, 2019
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer.
Roche launches HER2 biomarker test for breast and gastric cancer pharmatimes
May 09, 2019
Roche has launched a new assay that can detect the HER2 biomarker in breast and gastric cancer in the UK.
Breakdown of Blood-Brain Barrier May Drive Dementia drugs
January 16, 2019
Breakdown of the blood-brain barrier (BBB) may be an early biomarker of cognitive dysfunction, independent of amyloid or tau marker status, according to a study published online Jan. 14 in Nature Medicine....
Leap Therapeutics Announces an Investigator-Initiated Study of DKN-01 americanpharmaceuticalreview
January 15, 2019
Leap Therapeutics announced an investigator-initiated study led by David R. Wise, M.D., Ph.D. of the Perlmutter Cancer Center at NYU Langone Health to study DKN-01......
Biocartis, AstraZeneca aim faster lung cancer biomarker results biospectrumasia
December 05, 2018
Many lung cancers are driven by mutations in the epidermal growth factor receptor (EGFR), which occur in 10-15% of NSCLC patients in the US and the EU, and 30-40% of NSCLC patients in Asia.

Previous page 1 2 Next page